| |
| |
|
| Insider
Information: |
Papa Joseph C |
| Relationship: |
Director |
| City: |
Corona |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
1,952,222 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$17,736,946 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,952,222 |
|
|
| Total
Value |
$17,736,946 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 26.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cardinal Health Inc |
CAH |
Chmn & CEO, Pharm Tech... |
2004-12-13 |
14,400 |
|
0 |
Premium* |
|
|
Perrigo Co |
PRGO |
President and CEO, Cha... |
2013-12-18 |
0 |
2006-10-09 |
0 |
Premium* |
|
|
Bausch Health Companies Inc |
BHC |
Director |
2022-05-10 |
1,427,568 |
2016-05-02 |
0 |
Premium* |
|
|
Prometheus Biosciences, Inc. |
RXDX |
Director |
2023-06-16 |
0 |
2023-06-16 |
0 |
Premium* |
|
|
Bausch & Lomb Corp |
BLCO |
CEO & Chairman, Director |
2022-05-05 |
472,222 |
2022-05-05 |
0 |
Premium* |
|
|
Candel Therapeutics, Inc. |
CADL |
Director |
2022-12-09 |
38,032 |
2022-12-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
137 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2012-07-18 |
4 |
AS |
$114.06 |
$1,149,452 |
D/D |
(10,000) |
100,000 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2012-07-18 |
4 |
OE |
$20.50 |
$228,992 |
D/D |
10,000 |
101,563 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2012-08-30 |
4 |
AS |
$109.04 |
$1,091,741 |
D/D |
(10,000) |
115,645 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2012-08-30 |
4 |
OE |
$20.50 |
$205,000 |
D/D |
10,000 |
125,645 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2013-06-14 |
4 |
OE |
$35.85 |
$358,500 |
D/D |
10,000 |
110,000 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2013-06-14 |
4 |
AS |
$118.31 |
$1,183,910 |
D/D |
(10,000) |
100,000 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2013-07-11 |
4 |
OE |
$35.85 |
$358,500 |
D/D |
10,000 |
110,000 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2013-07-11 |
4 |
AS |
$128.44 |
$1,285,355 |
D/D |
(10,000) |
100,000 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Director |
– • – |
2023-06-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,000) |
7,278 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Director |
– • – |
2023-06-02 |
4 |
A |
$0.00 |
$0 |
I/I |
10,000 |
10,000 |
0 |
- |
|
| RXDX |
Prometheus Biosciences, I... |
Director |
– • – |
2023-06-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,000) |
0 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2011-11-22 |
4 |
AS |
$89.42 |
$910,388 |
D/D |
(10,180) |
111,412 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2013-04-09 |
4 |
AS |
$118.29 |
$1,261,046 |
D/D |
(10,645) |
100,000 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2010-08-30 |
4 |
D |
$57.62 |
$688,098 |
D/D |
(11,942) |
124,737 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
Chmn & CEO, Pharm Techn & Svcs |
• – – |
2004-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
14,400 |
|
- |
|
| BHC |
Bausch Health Companies I... |
CHAIRMAN & CEO |
• • – |
2022-03-03 |
4 |
D |
$23.61 |
$298,501 |
D/D |
(12,643) |
1,095,152 |
0 |
- |
|
| BHC |
Bausch Health Companies I... |
Chairman & CEO |
• • – |
2022-02-26 |
4 |
D |
$24.35 |
$321,006 |
D/D |
(13,183) |
1,126,116 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2011-02-22 |
4 |
OE |
$17.29 |
$259,350 |
D/D |
15,000 |
130,337 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2011-03-22 |
4 |
OE |
$17.29 |
$297,324 |
D/D |
15,000 |
130,337 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2011-04-25 |
4 |
OE |
$20.50 |
$307,500 |
D/D |
15,000 |
124,337 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2012-09-21 |
4 |
OE |
$30.06 |
$450,900 |
D/D |
15,000 |
130,645 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2012-09-21 |
4 |
AS |
$115.72 |
$1,748,831 |
D/D |
(15,000) |
115,645 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2012-10-10 |
4 |
OE |
$30.06 |
$450,900 |
D/D |
15,000 |
130,645 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2012-10-10 |
4 |
AS |
$117.23 |
$1,760,554 |
D/D |
(15,000) |
115,645 |
0 |
- |
|
| PRGO |
Perrigo Co |
President and CEOChairman |
• • – |
2012-11-15 |
4 |
AS |
$100.75 |
$1,511,747 |
D/D |
(15,000) |
115,645 |
0 |
- |
|
137 Records found
|
|
Page 3 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
